MacArthur Court Acquisition Corp

ProSomnus is a medical technology company specializing in the development and manufacture of precision oral appliance therapy (OAT) for Obstructive Sleep Apnea (OSA). The company's devices, such as the ProSomnus EVO, are designed as non-invasive alternatives to CPAP therapy, utilizing advanced CAD/CAM technology to ensure a personalized and comfortable fit for patients. By providing high-precision, patient-specific solutions, ProSomnus aims to improve treatment adherence and clinical outcomes for those suffering from sleep-disordered breathing. The company became a public entity in December 2022 following its business combination with MacArthur Court Acquisition Corp. ProSomnus continues to expand its product portfolio with innovations in remote patient monitoring and digital sleep medicine workflows.